| Previous Close | 51.41 |
| Open | 51.39 |
| Bid | 51.66 x 1700 |
| Ask | 51.67 x 500 |
| Day's Range | 51.39 - 51.83 |
| 52 Week Range | 37.38 - 52.60 |
| Volume | 2,068,312 |
| Avg. Volume | 5,273,107 |
| Market Cap | 89.79B |
| Beta | 1.63 |
| PE Ratio (TTM) | 72.38 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.06 (2.05%) |
| Ex-Dividend Date | 2017-07-12 |
| 1y Target Est | N/A |
Markit•yesterdaySee what the IHS Markit Score report has to say about Abbott Laboratories.
Abbott Laboratories NYSE:ABT
- Market Realist•2 days ago
Abbott Laboratories’ 375th Consecutive Quarterly Dividend
On September 14, 2017, Abbott Laboratories (ABT) announced its 375th consecutive quarterly dividend to be paid on November 15, 2017.
- Market Realist•5 days ago
The Latest Analyst Recommendations for Abbott Laboratories
Abbott Laboratories (ABT) released its 2Q17 earnings results on July 20, 2017, reporting strong results for revenues as well as earnings and exceeding Wall Street's estimates.
